Establishment of reference values for endocrine tests. II: Hyperprolactinemia
- PMID: 10474275
- DOI: 10.1016/s0300-2977(99)00040-6
Establishment of reference values for endocrine tests. II: Hyperprolactinemia
Abstract
Background: In patients with hyperprolactinemia, the thyrotropin-releasing hormone (TRH) stimulation test is widely applied to distinguish prolactinoma from other causes of hyperprolactinemia. In the present study, we established reference values for the plasma concentration of prolactin (PRL) and its response to TRH.
Methods: Basal PRL and the PRL response to 400 micrograms TRH i.v. was determined in 50 subjects recruited from the general population, equally distributed according to sex and age between 20 and 69 years. PRL was determined by a fluoroimmunometric assay. Reference values are given as the observed range.
Results: Plasma concentrations of PRL were 4.0-25 micrograms/l (median: 10.0 micrograms/l) in women and 0.5-19.0 micrograms/l (median: 8.5 micrograms/l) in men (p = 0.11). The peak PRL concentration after stimulation with TRH was slightly higher in women (median: 51 micrograms/l) than in men (median: 41 micrograms/l; p = 0.04) and was reached at t = 20 min in all subjects. The relative increase in plasma PRL (median: 440%) did not show a statistically significant effect of age or sex. In 12 subjects (24%), the relative increase in plasma PRL was lower than 250%, which has traditionally been considered the minimum cutoff for a normal response. There were no effects of smoking and alcohol, but regular ingestion of liquorice was associated with lower basal (p = 0.03) and lower stimulated (p = 0.05) plasma concentrations of PRL.
Conclusions: The present study provides reference values for basal and TRH-stimulated plasma concentrations of PRL.
Similar articles
-
Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.Neth J Med. 2003 Feb;61(2):44-8. Neth J Med. 2003. PMID: 12735420
-
Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.J Clin Endocrinol Metab. 2001 Apr;86(4):1562-7. doi: 10.1210/jcem.86.4.7382. J Clin Endocrinol Metab. 2001. PMID: 11297584
-
TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.J Endocrinol Invest. 1996 May;19(5):293-7. doi: 10.1007/BF03347865. J Endocrinol Invest. 1996. PMID: 8796337
-
Control of prolactin secretion.Klin Wochenschr. 1990 Dec 4;68(23):1157-67. doi: 10.1007/BF01815271. Klin Wochenschr. 1990. PMID: 2126309 Review.
-
[Hyperprolactinemia. II. Diagnosis and treatment].Przegl Lek. 1999;56(12):807-11. Przegl Lek. 1999. PMID: 10789194 Review. Polish.
Cited by
-
Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptor-expressing human cells.Endocrinology. 2009 Apr;150(4):1782-90. doi: 10.1210/en.2008-1057. Epub 2008 Nov 20. Endocrinology. 2009. PMID: 19022890 Free PMC article.
-
Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.Pituitary. 2012 Dec;15(4):472-81. doi: 10.1007/s11102-011-0353-9. Pituitary. 2012. PMID: 21993601 Free PMC article.
-
The prolactin receptor is expressed in rheumatoid arthritis and psoriatic arthritis synovial tissue and contributes to macrophage activation.Rheumatology (Oxford). 2016 Dec;55(12):2248-2259. doi: 10.1093/rheumatology/kew316. Epub 2016 Sep 10. Rheumatology (Oxford). 2016. PMID: 27616146 Free PMC article.
-
Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause.J Hum Hypertens. 2017 Aug;31(8):520-524. doi: 10.1038/jhh.2017.15. Epub 2017 Mar 23. J Hum Hypertens. 2017. PMID: 28332508
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical